Enzo biochem inc (ENZ)
CashFlow / Yearly
Jul'19Jul'18Jul'17Jul'16Jul'15Jul'14Jul'13Jul'12Jul'11Jul'10
Cash flows from operating activities:
Net loss

2,489

-10,321

-2,504

45,286

-2,285

-9,977

-18,237

-39,269

-12,960

-22,233

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization of property, plant and equipment

2,194

2,138

2,078

2,163

2,019

2,131

2,615

2,817

2,962

2,727

Amortization of intangible assets

842

992

1,520

1,677

1,770

1,840

1,990

1,660

1,507

1,542

Provision for uncollectible accounts receivable

-

-

-

2,336

2,284

3,063

4,496

5,104

4,431

3,480

Deferred income tax benefit

-

-

-

-60

-104

-18

-759

-1,762

17

-45

Share-based compensation charges

939

813

831

525

429

594

545

719

1,049

1,170

Share-based 401(k) employer match expense

855

829

724

709

662

636

643

649

690

1,115

Deferred revenue recognized

-

-

-

-

-

-

-

-400

-38

-450

Foreign exchange (gain) loss

-493

-475

476

-357

-664

304

127

-538

131

-45

Changes in operating assets and liabilities:
Impairment charges

-

-

-

-

-

-

-

24,540

-

-

Foreign currency transaction loss (gain)

-493

-475

476

-357

-664

-

-

-

-

-45

Accounts receivable

-2,404

-1,915

469

4,791

2,003

3,224

2,606

4,210

6,537

3,844

Other receivables - settlements

-

-

-

-6,650

6,650

-

-

-

-

-

Inventories

572

413

-92

-466

-1,151

-159

-60

-199

178

-681

Prepaid expenses and other assets

182

1,177

618

-

-

-

-

-

-

-

Prepaid expenses and other

-

-

-

-169

108

-336

97

-356

432

-220

Accounts payable – trade

-2,508

-887

515

1,103

394

-226

-514

1,031

1,462

2,348

Accrued liabilities, other current liabilities and other liabilities

-2,148

2,901

-1,898

-3,464

-1,923

3,293

1,975

2,056

-168

-220

Total adjustments

2,317

7,586

2,299

7,840

-1,415

8,280

8,221

33,297

4,634

8,769

Net cash used in operating activities

4,806

-2,735

-205

53,126

-3,700

-1,697

-10,016

-5,972

-8,326

-13,464

Cash flows from investing activities:
Capital expenditures

8,126

1,888

1,753

1,530

1,783

838

988

1,364

1,223

3,251

Maturities of short term investments

-

-

-

-

-

-

-

58,497

182,453

232,140

Purchases of short term investments

-

-

-

-

-

-

-

48,497

167,646

213,643

Increase (decrease) in security deposits and other

-

-56

4

18

31

5

17

-25

-45

81

Earn-out payment

-

-

-

-

-

-

-

1,150

-

-

Net cash used in investing activities

-8,126

-1,944

-1,749

-1,512

-1,752

-833

-971

7,461

13,539

15,327

Cash flows from financing activities:
Net proceeds from issuance of common stock

-

-

-

-

6,688

11,542

1,825

-

-

-

Proceeds from borrowing under mortgage agreement

4,500

-

40,694

89,880

88,632

78,814

13,360

-

-

-

Repayments under mortgage agreement, capital leases or Credit Agreement

404

-

42,250

91,336

88,632

79,065

10,096

-

-

-

Installment loan payments

-

-327

-566

-565

-463

-374

-274

-154

-68

-

Cost to obtain loan

70

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

167

886

453

90

-

-

-

-

-

-

Net cash (used in) provided by financing activities

4,193

559

-1,669

-1,931

6,225

10,917

4,815

-154

-68

-

Effect of exchange rate changes on cash and cash equivalents

-18

-6

13

-15

-119

61

103

-420

257

-33

Decrease in cash and cash equivalents and restricted cash

855

-4,126

-3,610

49,668

654

8,448

-6,069

915

5,402

1,830